Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 20 | $5,132,653 |
Sells | 28 | $2,712,339 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
31 Jan 2024 16:26 | TRML | Tourmaline Bio Inc | MCDADE MARK | Director | 29 Jan 2024 | Purchase | 100,000 | 32.5 | 3,250,000 | I |
20 Nov 2023 18:15 | TRML | Tourmaline Bio Inc | KULKARNI SANDEEP CHIDAMBAR | CEO | 17 Nov 2023 | Purchase | 4,000 | 16.99 | 67,960 | D |
20 Nov 2023 18:14 | TRML | Tourmaline Bio Inc | THIARA PARVINDER | Director | 17 Nov 2023 | Purchase | 1,000 | 17.31 | 17,310 | D |
27 Oct 2023 17:43 | TRML | Tourmaline Bio Inc | CASTELEIN CALEY | Director | 27 Oct 2023 | Purchase | 15,800 | 14.55 | 229,890 | D |
27 Oct 2023 17:43 | TRML | Tourmaline Bio Inc | CASTELEIN CALEY | Director | 25 Oct 2023 | Purchase | 4,200 | 12.07 | 50,694 | D |
26 Oct 2023 17:34 | TRML | Tourmaline Bio Inc | KULKARNI SANDEEP CHIDAMBAR | CEO | 26 Oct 2023 | Purchase | 5,000 | 12.25 | 61,250 | D |
26 Oct 2023 17:34 | TRML | Tourmaline Bio Inc | KULKARNI SANDEEP CHIDAMBAR | CEO | 24 Oct 2023 | Purchase | 4,650 | 10.68 | 49,662 | D |
26 Oct 2023 17:00 | TRML | Tourmaline Bio Inc | KANTOFF AARON | Director | 24 Oct 2023 | Purchase | 7,500 | 11.86 | 88,950 | D |
26 Oct 2023 16:46 | TRML | Tourmaline Bio Inc | THIARA PARVINDER | Director | 25 Oct 2023 | Purchase | 2,000 | 12.12 | 24,240 | D |
26 Oct 2023 16:46 | TRML | Tourmaline Bio Inc | THIARA PARVINDER | Director | 24 Oct 2023 | Purchase | 5,000 | 10.66 | 53,300 | D |
09 Jun 2023 17:41 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 09 Jun 2023 | Sale | 25,419 | 2.4642 | 62,637 | D |
09 Jun 2023 17:41 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 08 Jun 2023 | Sale | 40,642 | 2.4795 | 100,772 | D |
09 Jun 2023 17:41 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 07 Jun 2023 | Sale | 75,001 | 2.3879 | 179,095 | D |
07 Jun 2023 18:24 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 06 Jun 2023 | Sale | 25,549 | 2.5283 | 64,596 | D |
07 Jun 2023 18:24 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 05 Jun 2023 | Sale | 7,841 | 2.5194 | 19,755 | D |
05 Jun 2023 16:21 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 02 Jun 2023 | Sale | 15,818 | 2.5045 | 39,616 | D |
05 Jun 2023 16:21 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 01 Jun 2023 | Sale | 15,713 | 2.5569 | 40,177 | D |
25 Apr 2023 17:50 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 21 Apr 2023 | Sale | 15,004 | 2.3481 | 35,231 | D |
21 Apr 2023 07:57 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 20 Apr 2023 | Sale | 46,990 | 2.3263 | 109,313 | D |
21 Apr 2023 07:57 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 19 Apr 2023 | Sale | 21,753 | 2.1632 | 47,056 | D |
19 Apr 2023 09:22 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 18 Apr 2023 | Sale | 49,211 | 2.15 | 105,804 | D |
19 Apr 2023 09:22 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 17 Apr 2023 | Sale | 99,771 | 2.1402 | 213,530 | D |
07 Apr 2023 16:25 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 17 Mar 2023 | Sale A | 10,436 | 2.0643 | 21,543 | D |
07 Apr 2023 16:21 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 01 Mar 2023 | Sale A | 29 | 2.05 | 59 | D |
07 Apr 2023 16:23 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 03 Mar 2023 | Sale A | 6,806 | 2.0559 | 13,992 | D |
07 Apr 2023 16:17 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 17 Feb 2023 | Sale A | 3,612 | 2.0503 | 7,406 | D |
07 Apr 2023 16:17 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 16 Feb 2023 | Sale A | 2,939 | 2.0551 | 6,040 | D |
07 Apr 2023 16:19 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 21 Feb 2023 | Sale A | 3,500 | 2.0529 | 7,185 | D |
20 Mar 2023 16:36 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 17 Mar 2023 | Sale | 10,436 | 2.0643 | 21,543 | D |
07 Mar 2023 16:58 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 03 Mar 2023 | Sale | 6,806 | 2.0559 | 13,992 | D |
02 Mar 2023 17:26 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 01 Mar 2023 | Sale | 29 | 2.05 | 59 | D |
23 Feb 2023 17:01 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 21 Feb 2023 | Sale | 3,500 | 2.0529 | 7,185 | D |
21 Feb 2023 11:16 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 17 Feb 2023 | Sale | 3,612 | 2.0503 | 7,406 | D |
21 Feb 2023 11:16 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 16 Feb 2023 | Sale | 2,939 | 2.0551 | 6,040 | D |
13 Sep 2022 16:27 | TRML | Talaris Therapeutics Inc | NADER FRANCOIS | Director | 21 Jul 2022 | Purchase A | 36,500 | 3.72 | 135,780 | D |
13 Sep 2022 16:27 | TRML | Talaris Therapeutics Inc | NADER FRANCOIS | Director | 20 Jul 2022 | Purchase A | 52,000 | 3.62 | 188,240 | D |
13 Sep 2022 16:27 | TRML | Talaris Therapeutics Inc | NADER FRANCOIS | Director | 19 Jul 2022 | Purchase A | 50,000 | 3.52 | 176,000 | D |
23 Aug 2022 19:43 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Chief Scientific Officer | 22 Aug 2022 | Sale | 525,000 | 2.8 | 1,470,000 | D |
02 Aug 2022 17:02 | TRML | Talaris Therapeutics Inc | REQUADT SCOTT | Chief Executive Officer | 29 Jul 2022 | Purchase | 39,382 | 4.25 | 167,374 | D |
28 Jul 2022 19:52 | TRML | Talaris Therapeutics Inc | REQUADT SCOTT | Chief Executive Officer | 28 Jul 2022 | Purchase | 3,090 | 4.25 | 13,132 | D |
28 Jul 2022 19:52 | TRML | Talaris Therapeutics Inc | REQUADT SCOTT | Chief Executive Officer | 26 Jul 2022 | Purchase | 5,528 | 4.24 | 23,439 | D |
26 Jul 2022 19:38 | TRML | Talaris Therapeutics Inc | REQUADT SCOTT | Chief Executive Officer | 22 Jul 2022 | Purchase | 9,444 | 3.7497 | 35,412 | D |
25 Jul 2022 19:35 | TRML | Talaris Therapeutics Inc | NADER FRANCOIS | Director | 21 Jul 2022 | Purchase | 36,500 | 3.72 | 135,780 | D |
25 Jul 2022 19:35 | TRML | Talaris Therapeutics Inc | NADER FRANCOIS | Director | 20 Jul 2022 | Purchase | 52,000 | 3.62 | 188,240 | D |
25 Jul 2022 19:35 | TRML | Talaris Therapeutics Inc | NADER FRANCOIS | Director | 19 Jul 2022 | Purchase | 50,000 | 3.52 | 176,000 | D |
14 Jun 2023 18:58 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 14 Jun 2023 | Sale | 12,942 | 2.4914 | 32,244 | D |
14 Jun 2023 18:58 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 13 Jun 2023 | Sale | 14,208 | 2.5576 | 36,338 | D |
14 Jun 2023 18:58 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 12 Jun 2023 | Sale | 16,870 | 2.5919 | 43,725 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)